BMC Cancer

official impact factor 3.15

Open Access Highly Access Research article

Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy

Bekim Sadikovic1,2, Paul Thorner1, Susan Chilton-MacNeill1, Jeff W Martin4, Nilva K Cervigne3, Jeremy Squire4* and Maria Zielenska1,2

Author Affiliations

1 Department of Pediatric Laboratory Medicine, Pathology Division, Hospital for Sick Children, Toronto, M5G 1X8 Canada

2 Genetics and Genome Biology Program, Hospital for Sick Children, Toronto, ON, Canada

3 Division of Applied Molecular Oncology, Ontario Cancer Institute, the University Health Network, Toronto, M5G 2M9 Canada

4 Department of Pathology and Molecular Medicine, Richardson Labs, Queen's University, Kingston, K7L 3N6 Canada

For all author emails, please log on.

BMC Cancer 2010, 10:202 doi:10.1186/1471-2407-10-202

Published: 13 May 2010

Additional files

Additional file 1:

Primer sequences. Primer sequences for Real-Time PCR

Format: XLS Size: 29KB Download file

This file can be viewed with: Microsoft Excel Viewer

Open Data

Additional file 2:

Gene expression levels in osteosarcoma tumors and normal osteoblasts. Values of gene expression are represented as delta-delta Ct (log10).

Format: XLS Size: 21KB Download file

This file can be viewed with: Microsoft Excel Viewer

Open Data

Additional file 3:

Controls for qRT-PCR analyses. Respectively, A2M and SLC14A were the highest- and lowest- expressed genes in a previous microarray study performed by our group [19], and they were used to validate our conditions for the qRT-PCR experiments of the current study.

Format: TIFF Size: 1.5MB Download file

Open Data

Additional file 4:

Detailed results of the statistical analyses of gene expression. Tables represent values calculated using Mann-Whitney and 1-way ANOVA statistical analyses respectively

Format: XLS Size: 30KB Download file

This file can be viewed with: Microsoft Excel Viewer

Open Data